| Category | Zebrafish-specific findings (include quantitative numbers when available) | Key source(s) with year and URL | Notes/limitations |
|---|---|---|---|
| Identity/Family | UniProt Q9PUR2 corresponds to zebrafish **cryaba**, one of two teleost **αB-crystallin** paralogs (**cryaba/cryabb**) generated by genome duplication. cryaba encodes an ~**168 aa** small heat shock protein with ~**61% homology** to human CRYAB; zebrafish αB-crystallins retain canonical α-crystallin/sHSP architecture and chaperone function. CRISPR null lines plus adult lens mass spectrometry detected αBa peptide(s) in wild type and loss in **cryaba−/−**, confirming gene-protein identity. | Rossen et al., 2025, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2025.1552988; Posner et al., 2021, bioRxiv, https://doi.org/10.1101/2021.12.22.473921; Elicker & Hutson, 2007, Gene, https://doi.org/10.1016/j.gene.2007.08.003 | Strong identity evidence, but some details come from review synthesis and preprint support; domain architecture is inferred at family level rather than from a zebrafish cryaba-specific structure (pqac-00000001, pqac-00000002, pqac-00000003, pqac-00000005, pqac-00000007). |
| Molecular function | cryaba/αBa functions as an ATP-independent **small heat shock “holdase” chaperone** that binds destabilized proteins and limits aggregation. Compared with cryabb, cryaba shows **lower baseline chaperone activity** and may require stress-linked post-translational activation. In zebrafish lens biology, αB-crystallin also contributes to **lysosomal homeostasis**, with evidence that αB-crystallin stabilizes the **ATP6V1A–mTORC1** complex to maintain lysosomal acidity. | Zou et al., 2015, Exp Eye Res, https://doi.org/10.1016/j.exer.2015.07.001; Rossen et al., 2025, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2025.1552988 | Client specificity for zebrafish cryaba is not well resolved; much mechanistic detail on lysosomal complex stabilization is summarized through review of zebrafish plus complementary mammalian work rather than a purified zebrafish cryaba biochemical assay (pqac-00000008, pqac-00000009, pqac-00000010). |
| Key pathways/regulation | A recent zebrafish study links cryaba to **proteostatic/oxidative stress crosstalk** with **Nrf2**. Combined loss of **nrf2** and **cryaba** in lens upregulated the **cholesterol biosynthesis pathway**, and pharmacologic lowering of cholesterol (atorvastatin/lovastatin) increased lens-defect penetrance, implicating sterol homeostasis in phenotype modification. Separately, **hsf4−/−** lenses show reduced cryaba expression and increased lysosomal pH, placing cryaba downstream of **Hsf4** in lens proteostasis. | Park et al., 2023, Front Mol Biosci, https://doi.org/10.3389/fmolb.2023.1185704; Rossen et al., 2025, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2025.1552988 | RNA-seq sample sizes in the Nrf2/cryab study were limited, and exact fold changes are not provided in the available evidence excerpts; pathway-level inference is stronger than single direct molecular-cascade proof for every step (pqac-00000008, pqac-00000011, pqac-00000014, pqac-00000021). |
| Expression & localization | During early development, cryaba is reported as predominantly **non-ocular** relative to cryaa, with expression noted across **brain, heart, skeletal muscle, liver** and some lens cell contexts in single-cell analyses; other recent summaries state cryaba becomes more **lens-restricted with maturation**. RT-PCR detected cryaba transcription from about **24 hpf**. Figure evidence from Park et al. shows tissue-level **cryaba/cryabb mRNA** measurements in lens and heart. | Rossen et al., 2025, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2025.1552988; Peng et al., 2024, Mol Vis, https://doi.org/10.63500/mv_v30_123; Park et al., 2023, Front Mol Biosci, https://doi.org/10.3389/fmolb.2023.1185704; Zou et al., 2015, Exp Eye Res, https://doi.org/10.1016/j.exer.2015.07.001 | Expression literature is somewhat inconsistent because developmental stage, assay type, and paralog separation differ across studies; explicit subcellular localization of zebrafish Cryaba remains limited in the provided evidence (pqac-00000012, pqac-00000014, pqac-00000015, pqac-00000016, pqac-00000021). |
| Phenotypes/knockout | Phenotypes are **context- and method-dependent**. CRISPR null studies reported **no significant early lens defects** in cryaba−/− larvae at **72–96 hpf**, whereas morpholino knockdown caused lens abnormalities in about **~50%** of embryos and could be partially rescued by rat Cryaa transgene expression. A later summary reports **~50%** of cryaba−/− adults developed **age-related cataract by 2 years** versus **~25%** in wild type/cryaa−/−. Double mutants (**cryaba−/−; cryabb−/−** or **cryaa−/−; cryaba−/−**) showed **75–95%** lens abnormality frequencies in one study. cryaba loss also contributes to **stress-induced heart edema**, worsened by nrf2 deficiency. | Posner et al., 2021, bioRxiv, https://doi.org/10.1101/2021.12.22.473921; Zou et al., 2015, Exp Eye Res, https://doi.org/10.1016/j.exer.2015.07.001; Park et al., 2023, Front Mol Biosci, https://doi.org/10.3389/fmolb.2023.1185704; Rossen et al., 2025, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2025.1552988 | This is the most conflicted area: morpholino, CRISPR, and background-dependent studies disagree on penetrance; heart-edema results are supported, but exact percentages were not available in the excerpts (pqac-00000013, pqac-00000016, pqac-00000017, pqac-00000018, pqac-00000019, pqac-00000020, pqac-00000022). |
| Applications/implementations | Zebrafish cryaba biology is being used to model **congenital/age-related cataract**, **proteostasis failure**, and **cardiac stress susceptibility**. Human disease alleles such as **CRYAB R120G** have been expressed/knocked in within zebrafish lens systems, producing **mild lens defects** that worsen on cryaba/cryabb-null backgrounds, supporting use of zebrafish for variant interpretation and modifier studies. | Wu et al., 2018, PLoS ONE, https://doi.org/10.1371/journal.pone.0207540; Park et al., 2023, Front Mol Biosci, https://doi.org/10.3389/fmolb.2023.1185704; Rossen et al., 2025, Front Cell Dev Biol, https://doi.org/10.3389/fcell.2025.1552988 | Most translational implementations involve zebrafish as a disease model rather than direct therapeutic targeting of endogenous cryaba; some cited studies are reviews or transgenic paradigms rather than native cryaba functional assays alone (pqac-00000000, pqac-00000008, pqac-00000017, pqac-00000019). |
| Recent structural/biomedical context | Although zebrafish cryaba itself lacks a 2023–2024 structure in the provided context, current CRYAB/HSPB5 research reinforces interpretation of cryaba as a **dynamic oligomeric sHSP chaperone** whose activity depends on **α-crystallin-domain assembly**, **NT-IXI interactions**, and oligomer remodeling. Recent human/vertebrate work also highlights CRYAB roles in **mitochondrial protection**, **anti-apoptosis**, aggregation disease, and tissue repair, providing a mechanistic framework relevant to zebrafish ortholog annotation. | McFarland et al., 2024, Nat Commun, https://doi.org/10.1038/s41467-024-54647-7; Wang et al., 2023, Int J Mol Sci, https://doi.org/10.3390/ijms25010471; Wang et al., 2024, JCI Insight, https://doi.org/10.1172/jci.insight.182209 | These biomedical/structural data are largely **non-zebrafish** and should be used for cautious orthology-based inference only, not as direct evidence for unique zebrafish cryaba localization or substrate repertoire (pqac-00000005). |


*Table: This table summarizes zebrafish cryaba (UniProt Q9PUR2) functional annotation evidence across identity, molecular function, regulation, expression, phenotypes, and translational context. It highlights zebrafish-specific findings where available and notes where conclusions rely on review synthesis or orthology-based inference.*